Carmine Selleri
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Cutaneous Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Cohort Study of Clinical Spectrum and Treatment Patterns.
Journal: Life (Basel, Switzerland)
Published: July 08, 2026
Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.
Journal: British journal of haematology
Published: February 25, 2026
Personalized Venetoclax Dose Adjustment in Unfit Acute Myeloid Leukemia Patients: A Real-Life Case Series Study.
Journal: Journal of personalized medicine
Published: February 25, 2026
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 22, 2026
Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case.
Journal: Cancer genetics
Published: January 17, 2026
Early Ibrutinib Dose Modifications in CLL: A Post Hoc Analysis of the Real-World EVIdeNCE Study.
Journal: Cancers
Published: January 08, 2026
Immunophenotypic Heterogeneity and Clonal Sweep in Acute Myeloid Leukemia Revealed by Flow Cytometry: A Case Series Study.
Journal: Journal of personalized medicine
Published: January 01, 2026
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).
Journal: Hematological oncology
Published: November 13, 2025
Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies.
Journal: International journal of laboratory hematology
Published: September 10, 2025
Rituximab maintenance in marginal zone lymphoma: Evidence from a real-world single center case series study.
Journal: Bulletin du cancer
Published: September 08, 2025
Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a single-center case series study.
Journal: Journal of cancer research and clinical oncology
Published: September 06, 2025
Last Updated: 09/26/2026